Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs cyclophosphamide vs mycophenolate in children with severe allergic purpuric nephritis
ChiCTR2200055323Phase 4Completed
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Aug 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in IgA vasculitis nephritis and Henoch-Schönlein Purpura (HSP) (3 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoint: Hematuria. Started Aug 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
IgA vasculitis nephritisHenoch-Schönlein Purpura (HSP)
Beyond the preview
Go deeper on ChiCTR2200055323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055323.